Canada Life
AGN

Canada Life’s Allergan plc AGN Stock Holding History

Canada Life’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-376,690
Closed -$67M – 2849
2020
Q1 		$67M Buy
376,690
+213,518
+131% +$40.2M 0.18% 128
2019
Q4 		$30.9M Sell
163,172
-200,938
-55% -$36.2M 0.07% 297
2019
Q3 		$61.3M Sell
364,110
-40,730
-10% -$6.64M 0.15% 162
2019
Q2 		$68.1M Buy
404,840
+191,255
+90% +$26.5M 0.16% 145
2019
Q1 		$31.2M Sell
213,585
-80,365
-27% -$11.7M 0.08% 239
2018
Q4 		$39.4M Buy
293,950
+129,353
+79% +$21.2M 0.11% 190
2018
Q3 		$31.5M Buy
164,597
+1,125
+0.7% +$207K 0.07% 255
2018
Q2 		$27.3M Buy
163,472
+3,118
+2% +$501K 0.06% 300
2018
Q1 		$26.9M Sell
160,354
-124,472
-44% -$20.9M 0.07% 291
2017
Q4 		$46.5M Buy
284,826
+118,188
+71% +$21.2M 0.11% 206
2017
Q3 		$34.1M Buy
166,638
+22,804
+16% +$5.3M 0.08% 240
2017
Q2 		$34.9M Buy
143,834
+25,914
+22% +$6.09M 0.09% 237
2017
Q1 		$28.2M Sell
117,920
-4,043
-3% -$942K 0.08% 258
2016
Q4 		$25.7M Sell
121,963
-24,131
-17% -$5M 0.07% 268
2016
Q3 		$33.7M Sell
146,094
-283,271
-66% -$69.2M 0.1% 218
2016
Q2 		$99M Buy
429,365
+62,924
+17% +$14.5M 0.3% 79
2016
Q1 		$98.1M Buy
366,441
+216,624
+145% +$62M 0.36% 68
2015
Q4 		$46.9M Buy
149,817
+74,768
+100% +$22.3M 0.18% 128
2015
Q3 		$20.3M Sell
75,049
-165,374
-69% -$50.8M 0.08% 252
2015
Q2 		$72.9M Sell
240,423
-212,943
-47% -$63.5M 0.25% 89
2015
Q1 		$135M Buy
453,366
+76,009
+20% +$21.7M 0.46% 45
2014
Q4 		$97.2M Sell
377,357
-19,337
-5% -$4.83M 0.32% 74
2014
Q3 		$95.8M Buy
396,694
+46,476
+13% +$10.4M 0.32% 70
2014
Q2 		$77.8M Buy
350,218
+34,387
+11% +$7.12M 0.25% 97
2014
Q1 		$64.7M Buy
315,831
+21,049
+7% +$4.17M 0.23% 99
2013
Q4 		$49.7M Buy
294,782
+114,001
+63% +$17.8M 0.18% 123
2013
Q3 		$26M Buy
180,781
+2,379
+1% +$317K 0.1% 201
2013
Q2 		$22.5M Buy
+178,402
New +$20.2M 0.15% 130

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Canada Life's AGN Position: Q2 2020 in Review

Canada Life sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 376,690 shares — an estimated $67M sold.

Canada Life first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $135M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Canada Life reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Canada Life sold 376,690 Allergan plc shares in Q2 2020, an estimated $67M.
  • Canada Life first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Canada Life's Allergan plc position peaked at $135M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Canada Life's 13F filing for Q2 2020, filed 17 Aug 2020.